Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFood takes noticeably longer to leave the stomach on Wegovy than it would otherwise. Semaglutide slows gastric emptying — the pace at which your stomach pushes food into the small intestine — and most people feel fuller for several hours after a small meal. That effect is intentional and central to how the medicine supports weight loss, but it also explains a handful of practical experiences worth understanding before you start. These are prescription-only medicines: a qualified prescriber assesses whether Wegovy is appropriate for your specific situation before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and the mechanism is well-established. Semaglutide binds to GLP-1 receptors in the gut wall and brain, triggering a signal that tells the stomach to slow its contractions. The technical term is delayed gastric emptying. Food that might ordinarily clear the stomach in roughly two to four hours can take considerably longer, studies in the semaglutide programme show the effect is detectable from the first dose.
This is not a bug. The slower transit gives digestion more time and keeps fullness hormones elevated, which is why people on Wegovy often describe eating a third of a normal portion and feeling done. The NHS patient information for semaglutide lists nausea, burping, reflux and constipation as the most common early complaints, all consistent with food sitting in the stomach longer and the gut adapting to a new rhythm.
The effect is strongest at the start of treatment and after each dose step up. Most people notice it settle within days to a couple of weeks as their digestive system adjusts. It does not mean digestion stops working; it means it slows. Nutrients are still absorbed, just over a longer window.
Slower gastric emptying is directly behind the most talked-about early experiences on Wegovy. Nausea is the most reported one, and it tends to peak in the hour or two after eating. Reflux and burping happen because the stomach is fuller for longer, which can push stomach acid upward. Constipation is also common, when content moves slowly out of the stomach, it moves slowly through the rest of the gut too.
A practical habit worth building straight away: keep a loose track of how long you feel full after meals in the first couple of weeks. Most people find that a meal they could once eat within twenty minutes now keeps them comfortable for three to four hours. If fullness is lasting six or more hours, or is accompanied by significant nausea or vomiting, that is worth flagging to your prescriber rather than pushing through a dose increase.
Meal composition makes a genuine difference. High-fat meals slow gastric emptying even under normal circumstances; on Wegovy, adding fat to an already-delayed system can amplify nausea significantly. Smaller portions, lower in fat, eaten slowly tend to cause far fewer symptoms than large or greasy meals. Staying well hydrated helps the gut keep moving, too.
Understanding how quickly you can expect to feel the medicine's other effects is useful context, our page on how long Wegovy takes to work covers the broader timeline of appetite and weight changes.
Research suggests the gastric-emptying effect of semaglutide is most pronounced early and tends to diminish somewhat over months of treatment, even as weight loss continues. That is one reason the appetite-suppressing effect of GLP-1 medicines is thought to be partly central (brain-based) as well as gut-based, the signal to eat less keeps working even as the stomach adapts to the new pace.
In the STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4mg achieved an average body-weight reduction of around 15% over 68 weeks, a sustained result that runs well beyond the period when gastric slowing is most acute. That tells you the weight-loss mechanism goes deeper than digestion alone.
For some people the gut adjustment is smooth. For others, particularly after each dose step, there is a temporary return of nausea or fullness. This is why dose titration is gradual, starting low gives the digestive system time to adapt before the dose rises. If you are curious about how long it takes to lose weight on Wegovy and what a realistic rate of progress looks like, that page sets the broader results picture out in detail.
If you are considering starting Wegovy and want to understand how it fits your situation, the team at nume includes GPhC-registered prescribers who review every consultation personally. There is no algorithm making the decision. You can also read about the wider range of weight-loss treatment options to see what might suit you before you go further.
Most digestive symptoms on Wegovy are mild to moderate and settle with time. A few, though, need prompt attention. Severe stomach pain (particularly pain that is persistent and radiates toward the back, with or without vomiting) should not be dismissed as ordinary nausea. The MHRA highlighted acute pancreatitis as a known, infrequent but serious risk associated with GLP-1 medicines in a Drug Safety Update in January 2026; that symptom pattern is the key warning sign.
Gallbladder problems (pain in the upper right abdomen, especially after eating) are also more common in people losing weight rapidly, and GLP-1 medicines are associated with an increased gallstone risk. If you develop that kind of pain, get it checked rather than waiting.
Severe vomiting that prevents keeping fluids down for more than a day or so can lead to dehydration. That matters for kidney function, so it warrants a call to your prescriber or GP sooner rather than later. Suspected side effects can be reported directly through the MHRA Yellow Card scheme.
For a fuller picture of what to expect as the medicine takes effect, the results timeline for Wegovy walks through the early weeks to month six and beyond. And if you have questions about whether Wegovy is the right treatment for you, including how it works and who it is suitable for, starting a free consultation with our prescribers is the clearest next step, and our page on how long it takes to get Wegovy explains what to expect from the process once you have decided to go ahead.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.